Related Experiment Video
Updated: Jul 13, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Paraneoplastic pemphigus associated with fludarabine use
Ozcan Yildiz1, Mustafa Ozguroglu, M Teoman Yanmaz
1Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Medical Oncology, Istanbul, Turkey.
Medical Oncology (Northwood, London, England)
|August 4, 2007
Summary
Fludarabine, a chemotherapy drug, may trigger paraneoplastic pemphigus, a severe skin condition, in patients with non-Hodgkin
Area of Science:
- Oncology
- Dermatology
- Immunology
Background:
- Paraneoplastic pemphigus is a rare, severe mucocutaneous disorder linked to B-cell lymphoproliferative diseases.
- Non-Hodgkin's lymphoma is a type of cancer affecting lymphocytes.
Observation:
- A 51-year-old male patient developed mucocutaneous lesions after undergoing six cycles of fludarabine therapy for non-Hodgkin's lymphoma.
- Skin biopsy revealed suprabasal acantholysis and blistering within the epidermis and upper dermis.
Findings:
- Direct immunofluorescence showed intercellular IgG deposition and complement (C3) at the basement membrane.
- Indirect immunofluorescence confirmed intercellular IgG binding, consistent with paraneoplastic pemphigus.
- The clinical presentation and biopsy results strongly suggest paraneoplastic pemphigus associated with fludarabine treatment.
Implications:
- The temporal relationship suggests a potential etiopathological link between fludarabine use and the development of paraneoplastic pemphigus.
- This case highlights the importance of considering drug-induced conditions in patients presenting with mucocutaneous lesions during chemotherapy.
- Further research is warranted to elucidate the mechanisms underlying fludarabine-induced paraneoplastic pemphigus.